Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection

The American Journal of Medicine

Volumn 82, Issue 6 SUPPL. 2, 1987, Pages 59-64

  Cox, Clair E ^a   McCabe, Robert E ^b   Grad, Christine ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFOTAXIME; MEZLOCILLIN; NORFLOXACIN; TICARCILLIN; VANCOMYCIN;

ADULT; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOLERANCE; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; SERRATIA; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; ANTIBIOTICS; ANTIBIOTICS, LACTAM; CLINICAL TRIALS; COMPARATIVE STUDY; CROSS INFECTION; FEMALE; HUMAN; MALE; MIDDLE AGE; NORFLOXACIN; OPPORTUNISTIC INFECTIONS; RANDOM ALLOCATION; URINARY TRACT INFECTIONS; VANCOMYCIN;

EID: 0023624139     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90620-6     Document Type: Article

References (21)

1. Occurrence of gram-negative bacteria in midstream bladder urine and their sensitivity to quinolone derivatives
2. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections
3. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates
4. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates
5. The antimicrobial spectrum of norfloxacin
6. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens
7. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance
8. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora
9. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections
10. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections
11. Experiences on the efficacy and safety of nalidixic acid, oxolinic acid, cinoxacin and norfloxacin in the treatment of urinary tract infections (UTI)
12. Treatment of acute urinary tract infection by norfloxacin or nalidixic acid/citrate: a multicenter comparative study
13. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections—a multicentre trial
14. The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin
15. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients
16. A review of urinary tract infection in the elderly
17. Nosocomial infection of urinary tract: changing pathogens, changing patterns
18. Infectious complications after instrumentation of urinary tract
19. Postoperative infection in urologic surgery
20. Problem pathogens in nosocomial infections of the urinary tract
21. Changing patterns of hospital associated infections